Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward
Jian Li, Wenwen Li, Kejia Huang, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 220

Showing 1-25 of 220 citing articles:

Translational Applications of Hydrogels
Santiago Correa, Abigail K. Grosskopf, Hector Lopez Hernandez, et al.
Chemical Reviews (2021) Vol. 121, Iss. 18, pp. 11385-11457
Open Access | Times Cited: 714
CAR T cells in solid tumors: challenges and opportunities
Faroogh Marofi, Roza Motavalli, В. А. Сафонов, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 449
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
Andrew M. K. Law, Fátima Valdés‐Mora, David Gallego‐Ortega
Cells (2020) Vol. 9, Iss. 3, pp. 561-561
Open Access | Times Cited: 379
Immunotherapy for pancreatic cancer: A 2020 update
Dimitriοs Schizas, Nikolaos Charalampakis, Christo Kole, et al.
Cancer Treatment Reviews (2020) Vol. 86, pp. 102016-102016
Closed Access | Times Cited: 359
Adoptive cellular therapies: the current landscape
Maartje W. Rohaan, Sofie Wilgenhof, John B.A.G. Haanen
Virchows Archiv (2018) Vol. 474, Iss. 4, pp. 449-461
Open Access | Times Cited: 346
T Cell Dysfunction and Exhaustion in Cancer
Zhen Zhang, Shasha Liu, Bin Zhang, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 303
Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
Anping Li, Ming Yi, Shuang Qin, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 286
Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
Shuang Qin, Anping Li, Ming Yi, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 282
Current Perspectives in Cancer Immunotherapy
Theodoulakis Christofi, Stavroula Baritaki, Luca Falzone, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1472-1472
Open Access | Times Cited: 185
Cancer Stem Cells and Targeting Strategies
Luisa Barbato, Marco Bocchetti, Anna Di Biase, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 926-926
Open Access | Times Cited: 173
Bispecific T-cell engagers: Towards understanding variables influencing the in vitro potency and tumor selectivity and their modulation to enhance their efficacy and safety
Diego Ellerman
Methods (2018) Vol. 154, pp. 102-117
Open Access | Times Cited: 171
Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment
Li Yang, Aitian Li, Qingyang Lei, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 164
Managing Metastatic Melanoma in 2022: A Clinical Review
Benjamin Switzer, Igor Puzanov, Joseph J. Skitzki, et al.
JCO Oncology Practice (2022) Vol. 18, Iss. 5, pp. 335-351
Open Access | Times Cited: 146
Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study
Mohsen Sheykhhasan, Hamed Manoochehri, Paola Dama
Cancer Gene Therapy (2022) Vol. 29, Iss. 8-9, pp. 1080-1096
Open Access | Times Cited: 107
Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment
Ting Yan, Zhu Lingfeng, Jin Chen
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 106
Current updates on generations, approvals, and clinical trials of CAR T-cell therapy
Tadesse Asmamaw Dejenie, Markeshaw Tiruneh G Medhin, Gashaw Dessie Terefe, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 94
MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors
Ali Kinkhabwala, Christoph Herbel, Jennifer Pankratz, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 89
Challenges and new technologies in adoptive cell therapy
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 81
Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance
Taniya Saha, Kiven Erique Lukong
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 77
Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions
Alaa Alnefaie, Sarah Albogami, Yousif A. Asiri, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 72
Cytokine release syndrome and cancer immunotherapies – historical challenges and promising futures
Deep Shah, Brian W. Soper, Lindsay S. Shopland
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 41
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 28
Tumor‐Tailored Ionizable Lipid Nanoparticles Facilitate IL‐12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapy
Shufen Xu, Yue Xu, Nicholas C. Solek, et al.
Advanced Materials (2024) Vol. 36, Iss. 29
Closed Access | Times Cited: 24
Emerging therapies for non-small cell lung cancer
Chao Zhang, Natasha B. Leighl, Yi‐Long Wu, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 143
Macrophage targeting: opening new possibilities for cancer immunotherapy
Luca Cassetta, Takanori Kitamura
Immunology (2018) Vol. 155, Iss. 3, pp. 285-293
Open Access | Times Cited: 141
Page 1 - Next Page

Scroll to top